Young-Joon Ko (Y-J Ko)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 26

Top Topics

Silver Nanoparticles

Wastewater Treatment

Tandem Mass Spectrometry

Top Venues

Pathogens (Basel, Switzerland)

Clinical and experimental vaccine research

This page only lists publications with an associated author ORCID identifier.

Publications

Jae Young Kim, Sun Young Park, Gyeongmin Lee, Sang Hyun Park, Jong-Sook Jin, Dohyun Kim, Jong-Hyeon Park, Seong-Yun Jeong, Young-Joon Ko
Determination of Optimal Antigen Yield and Virus Inactivation Conditions for the Production of the Candidate Foot-and-Mouth Disease Recombinant Vaccine Strain Asia1 Shamir-R in a Bioreactor. Viruses 16 (3) (2024)
Dohyun Kim, Sun Young Park, Gyeongmin Lee, Eun-Sol Kim, Jong-Sook Jin, Jae Young Kim, SooAh Lee, Jong-Hyeon Park, Young-Joon Ko
Calcium Chloride Treatment Enhances Antigen Production in Foot-and-Mouth Disease Vaccines for Serotypes SAT1 and SAT3. Vaccines 12 (3) (2024)
Jae Young Kim, Sun Young Park, Gyeongmin Lee, Sang Hyun Park, Jong-Sook Jin, Dohyun Kim, Jong-Hyeon Park, Seong-Yun Jeong, Young-Joon Ko
Determination of Optimal Antigen Yield and Virus Inactivation Conditions for the Production of the Candidate Foot-and-Mouth Disease Recombinant Vaccine Strain Asia1 Shamir-R in a Bioreactor. Viruses 16 (3) (2024)
Jong Sook Jin, Gyeongmin Lee, Jae Young Kim, SooAh Lee, Jong-Hyeon Park, Sun Young Park, Young-Joon Ko
Calcium Chloride as a Novel Stabilizer for Foot-and-Mouth Disease Virus and Its Application in the Vaccine Formulation. Vaccines 12 (4) (2024)
Jae Young Kim, Sun Young Park, Gyeongmin Lee, Sang Hyun Park, Jong-Sook Jin, Dohyun Kim, Jong-Hyeon Park, Seong-Yun Jeong, Young-Joon Ko
Determination of Optimal Antigen Yield and Virus Inactivation Conditions for the Production of the Candidate Foot-and-Mouth Disease Recombinant Vaccine Strain Asia1 Shamir-R in a Bioreactor. Viruses 16 (3) (2024)
Dohyun Kim, Sun Young Park, Gyeongmin Lee, Eun-Sol Kim, Jong-Sook Jin, Jae Young Kim, SooAh Lee, Jong-Hyeon Park, Young-Joon Ko
Calcium Chloride Treatment Enhances Antigen Production in Foot-and-Mouth Disease Vaccines for Serotypes SAT1 and SAT3. Vaccines 12 (3) (2024)
Dohyun Kim, Sun Young Park, Gyeongmin Lee, Eun-Sol Kim, Jong-Sook Jin, Jae Young Kim, SooAh Lee, Jong-Hyeon Park, Young-Joon Ko
Calcium Chloride Treatment Enhances Antigen Production in Foot-and-Mouth Disease Vaccines for Serotypes SAT1 and SAT3. Vaccines 12 (3) (2024)
Jae Young Kim, Sun Young Park, Sang Hyun Park, Gyeongmin Lee, Jong-Sook Jin, Dohyun Kim, Jong-Hyeon Park, Seong-Yun Jeong, Young-Joon Ko
Evaluation of Foot-and-Mouth Disease (FMD) Virus Asia1 Genotype-V as an FMD Vaccine Candidate: Study on Vaccine Antigen Production Yield and Inactivation Kinetics. Vaccines 12 (2) (2024)
Jae Young Kim, Sun Young Park, Sang Hyun Park, Gyeongmin Lee, Jong-Sook Jin, Dohyun Kim, Jong-Hyeon Park, Seong-Yun Jeong, Young-Joon Ko
Evaluation of Foot-and-Mouth Disease (FMD) Virus Asia1 Genotype-V as an FMD Vaccine Candidate: Study on Vaccine Antigen Production Yield and Inactivation Kinetics. Vaccines 12 (2) (2024)
Jong Sook Jin, Gyeongmin Lee, Jae Young Kim, SooAh Lee, Jong-Hyeon Park, Sun Young Park, Young-Joon Ko
Calcium Chloride as a Novel Stabilizer for Foot-and-Mouth Disease Virus and Its Application in the Vaccine Formulation. Vaccines 12 (4) (2024)
Jae Young Kim, Sun Young Park, Gyeongmin Lee, Sang Hyun Park, Jong-Sook Jin, Dohyun Kim, Jong-Hyeon Park, Seong-Yun Jeong, Young-Joon Ko
Determination of Optimal Antigen Yield and Virus Inactivation Conditions for the Production of the Candidate Foot-and-Mouth Disease Recombinant Vaccine Strain Asia1 Shamir-R in a Bioreactor. Viruses 16 (3) (2024)
Jae Young Kim, Sun Young Park, Gyeongmin Lee, Sang Hyun Park, Jong-Sook Jin, Dohyun Kim, Jong-Hyeon Park, Seong-Yun Jeong, Young-Joon Ko
Determination of Optimal Antigen Yield and Virus Inactivation Conditions for the Production of the Candidate Foot-and-Mouth Disease Recombinant Vaccine Strain Asia1 Shamir-R in a Bioreactor. Viruses 16 (3) (2024)
Jae Young Kim, Ji-Hye Lee, Jong Min Yang, Seo-Yong Lee, Sun Young Park, Jong Sook Jin, Dohyun Kim, Jung-Won Park, Jong-Hyeon Park, Sang Hyun Park, Young-Joon Ko
Production of Foot-and-Mouth Disease Type O and A Vaccine Antigens on a Pilot Scale and Determination of Optimal Amount of Antigen for Monovalent Vaccines. Vaccines 11 (7) (2023)
Jae Young Kim, Sun Young Park, Jong Sook Jin, Dohyun Kim, Jong-Hyeon Park, Sang Hyun Park, Young-Joon Ko
Efficacy of Binary Ethylenimine in the Inactivation of Foot-and-Mouth Disease Virus for Vaccine Production in South Korea. Pathogens (Basel, Switzerland) 12 (6) (2023)
Jae Young Kim, Sun Young Park, Jong Sook Jin, Dohyun Kim, Jong-Hyeon Park, Sang Hyun Park, Young-Joon Ko
Efficacy of Binary Ethylenimine in the Inactivation of Foot-and-Mouth Disease Virus for Vaccine Production in South Korea. Pathogens (Basel, Switzerland) 12 (6) (2023)
Ah-Young Kim, Sun Young Park, Sang Hyun Park, Jae Young Kim, Jong Sook Jin, Eun-Sol Kim, Jong-Hyeon Park, Young-Joon Ko
Comparison of High-Performance Liquid Chromatography with Sucrose Density Gradient Ultracentrifugation for the Quantification of Foot-and-Mouth Disease Vaccine Antigens. Vaccines 10 (5) (2022)
Sun Young Park, Jong Sook Jin, Dohyun Kim, Jae Young Kim, Sang Hyun Park, Jong-Hyeon Park, Choi-Kyu Park, Young-Joon Ko
Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus. Pathogens (Basel, Switzerland) 11 (12) (2022)
Sun Young Park, Sim-In Lee, Jong Sook Jin, Eun-Sol Kim, Jae Young Kim, Ah-Young Kim, Sang Hyun Park, Jung-Won Park, Soonyong Park, Eun Gyo Lee, Jong-Hyeon Park, Young-Joon Ko, Choi-Kyu Park
Factors Involved in Removing the Non-Structural Protein of Foot-and-Mouth Disease Virus by Chloroform and Scale-Up Production of High-Purity Vaccine Antigens. Vaccines 10 (7) (2022)
Sun Young Park, Jong Sook Jin, Dohyun Kim, Jae Young Kim, Sang Hyun Park, Jong-Hyeon Park, Choi-Kyu Park, Young-Joon Ko
Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus. Pathogens (Basel, Switzerland) 11 (12) (2022)
Sun Young Park, Jong Sook Jin, Dohyun Kim, Jae Young Kim, Sang Hyun Park, Jong-Hyeon Park, Choi-Kyu Park, Young-Joon Ko
Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus. Pathogens (Basel, Switzerland) 11 (12) (2022)
Sun Young Park, Jong Sook Jin, Dohyun Kim, Jae Young Kim, Sang Hyun Park, Jong-Hyeon Park, Choi-Kyu Park, Young-Joon Ko
Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus. Pathogens (Basel, Switzerland) 11 (12) (2022)
A-Y Kim, H Kim, S Y Park, S H Park, J-M Lee, J-S Kim, J-W Park, C-K Park, J-H Park, Young-Joon Ko
Investigation of the optimal medium and application strategy for foot-and-mouth disease vaccine antigen production. Journal of applied microbiology 131 (3) (2021)
Sang-Hyun Park, Seo-Yong Lee, Jae-Seok Kim, Ah-Young Kim, Sun-Young Park, Ji-Hye Lee, Mijung Lee, Hyejin Kim, Sim-In Lee, Na-Young Kang, Jung-Won Park, Su Mi Kim, Jong-Hyeon Park, Young-Joon Ko
Scale-Up Production of Type O and A Foot-and-Mouth Disease Bivalent Vaccine and Its Protective Efficacy in Pigs. Vaccines 9 (6) (2021)
Ah-Young Kim, Sun Young Park, Sang Hyun Park, Jong Sook Jin, Eun-Sol Kim, Jae Young Kim, Jong-Hyeon Park, Young-Joon Ko
Validation of Pretreatment Methods for the In-Process Quantification of Foot-and-Mouth Disease Vaccine Antigens. Vaccines 9 (11) (2021)
Jong-Hyeon Park, Dongseob Tark, Kwang Nyeong Lee, Seo-Yong Lee, Mi-Kyeong Ko, Hyang-Sim Lee, Su Mi Kim, Young-Joon Ko, Min-Goo Seo, Ji-Eun Chun, Myoung-Heon Lee, Byounghan Kim
Novel foot-and-mouth disease virus in Korea, July-August 2014. Clinical and experimental vaccine research 5 (1) (2016)
Rae-Hyung Kim, Jia-Qi Chu, Jeong-Nam Park, Seo-Yong Lee, Yeo-Joo Lee, Mi-Kyeong Ko, Ji Hyeon Hwang, Kwang Nyeong Lee, Su Mi Kim, Dongseob Tark, Young-Joon Ko, Hyang-Sim Lee, Min-Goo Seo, Byounghan Kim, Byounghan Kim, Jong-Hyeon Park
Antigenic properties and virulence of foot-and-mouth disease virus rescued from full-length cDNA clone of serotype O, typical vaccine strain. Clinical and experimental vaccine research 4 (1) (2015)